RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 86 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,730,482 | +235.8% | 380,828 | +122.9% | 0.29% | +327.9% |
| Q1 2020 | $2,600,000 | -33.7% | 170,859 | 0.0% | 0.07% | -12.8% |
| Q4 2019 | $3,922,000 | -32.2% | 170,859 | -35.0% | 0.08% | -41.4% |
| Q2 2019 | $5,785,000 | -58.0% | 262,970 | -47.7% | 0.13% | -65.8% |
| Q1 2019 | $13,786,000 | +0.2% | 502,970 | -1.2% | 0.39% | -25.8% |
| Q4 2018 | $13,763,000 | -29.0% | 509,186 | -23.3% | 0.52% | +1.2% |
| Q3 2018 | $19,374,000 | -22.6% | 664,186 | -17.0% | 0.52% | -21.0% |
| Q2 2018 | $25,029,000 | +112.4% | 800,686 | +35.2% | 0.66% | +98.8% |
| Q1 2018 | $11,786,000 | -45.6% | 592,286 | -20.5% | 0.33% | -54.0% |
| Q4 2017 | $21,654,000 | – | 745,135 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |